Search

everythinglearnresearchcommunity

for

Search:↓

A user in their early 20s is concerned about minor hair thinning and is considering a hair loss regimen involving PRP sessions, mesotherapy with dutasteride injections, and low-dose finasteride. They dislike minoxidil due to its greasiness and prefer a routine that is easy to maintain.

PP405 is considered a promising potential cure for hair loss, with phase 2 trial results expected in February 2025. Hair cloning is also discussed as a potential ultimate solution, despite significant scientific challenges.

A 25-year-old male experienced noticeable temple regrowth using 1mg finasteride, 2.5mg oral minoxidil, and 2mg GHK-Cu over three months. The user is pleased with the progress, especially on the left temple.

User reports thicker, denser hair after 3 months of finasteride 1mg daily and keto shampoo every 3 days. No minoxidil or microneedling used.

A 21-year-old male shares a 3-month progress update using 1 mg oral finasteride daily and 5% topical minoxidil twice daily, reporting no side effects and noticeable hair growth. Users commend the results and encourage continuation of the treatment.

Kintor is producing a cosmetic with KX826, starting at 0.5% concentration and moving to 1%. The 0.5% concentration wasn't as effective as minoxidil and finasteride, but the 1% concentration shows promise.

A 24-year-old user shared their 3-month progress using a topical spray containing 0.3% finasteride and 6% minoxidil, along with dermarolling and Nizoral shampoo, reporting reduced shedding and signs of hair regrowth. They emphasized consistency in their routine and noted no side effects, expressing optimism about future results.

The user experienced successful hair regrowth over 610 days using Finasteride, Minoxidil, and Nizoral shampoo, with no side effects and improved mood. They encourage patience in the hair growth process.

The conversation is about a person's 3-month hair loss treatment using Minoxidil with crushed Finasteride tablets and weekly dermarolling. They shared their progress pictures.

The user experienced improved hair health and density after three months using 1mg finasteride and topical minoxidil twice daily, with no side effects. They also use ketoconazole 2% twice weekly and purchase their medications from Amazon.

The user "Matryxv" shared their progress with hair loss, using finasteride, minoxidil, ketoconazole, dermarolling, and other treatments. They achieved significant hair regrowth in a short amount of time, surprising both themselves and other users.

Kintor's 1% Pyrilutamide will be released in October/November. The user cannot tolerate finasteride.

Using the "big three" hair loss treatments (Minoxidil, Finasteride, and Ketoconazole) can initially make hair look worse, often causing dryness and a "straw" texture. Adjusting the routine with gentler shampoos and conditioners can improve hair appearance while waiting for the treatments to show results.

Hair loss treatments discussed: GT 20029, Pyrilutamide, Minoxidil, Finasteride, and Dutasteride. Some believe Dutasteride will replace Finasteride.

The user is happy with their 3-month hair loss treatment progress using 1mg finasteride daily, 5% minoxidil twice daily, derma stamping 1-2 times a week, and WaterMans shampoo. They noticed improvements despite initial shedding and stopped taking creatine, which they suspect might have affected hair loss.

A user shared their 3-month progress using oral minoxidil, finasteride, and topical minoxidil for hair loss. Another user commented on the significant improvement, hoping for similar results.

User took 0.5mg Finasteride daily and 1x Minoxidil daily for 3 months, experienced positive hair growth and temporary side effects. Recommends sticking with treatment and adjusting dosage if needed.

PP405 is a new hair loss treatment in phase 2 trials that may promote hair growth by increasing lactate production and activating hair follicle stem cells. It could potentially replace hormone-disrupting treatments like Minoxidil and finasteride.

The conversation discusses avoiding caffeine after Platelet-Rich Plasma (PRP) treatment for hair loss because caffeine is a vasoconstrictor, which can reduce blood flow and hinder the healing process that PRP aims to promote.

New hair loss treatments, including Breezula, VDPHL01, and PP405, are nearing Phase 3 trials, offering hope for effective solutions. Current treatments like finasteride and minoxidil remain effective, but early intervention is crucial.

The user experienced positive hair regrowth and thicker hair after 12 weeks on 1.25mg Finasteride and 2.5mg Minoxidil chewables, with no side effects. They plan to reassess the need for a hair transplant after seeing further progress.

A 22-year-old has been using finasteride (1.25mg), topical minoxidil once a day, and dermastamping weekly for three months with no side effects. The user is seeking feedback on hair regrowth progress, but results are inconclusive due to lighting and hair length differences in photos.

PP405 is a new hair loss treatment advancing quickly in trials, generating excitement and skepticism about its effectiveness and marketing claims. Some see it as a potential alternative to minoxidil and finasteride, but concerns about long-term effects and the need for DHT blockers persist.

The conversation is about using vitamin C and Magnesium L-Threonate for hair growth by reducing DHT binding to dermal papilla cells. The original post about vitamin C's pH levels and sebum control was possibly removed by a moderator.

The user experienced side effects from low-dose topical finasteride and is considering using clascoterone (CB-03-01) despite concerns about its risks and cost. They seek advice on its effectiveness and potential side effects compared to other treatments like alfatradiol and fluridil.

The user reported hair regrowth progress using minoxidil and dermapen, considering adding finasteride. Others shared experiences with minoxidil, finasteride, and microneedling, recommending finasteride for long-term results but noting potential side effects.

The user reported slight improvement in hairline using 1% Clascoterone cream over three months but found it too costly to continue. They expressed interest in trying a 5% concentration if it becomes available at a reasonable price.

A new topical treatment, TH07, combining finasteride, latanoprost, and minoxidil, is entering phase III trials with promising early results. Some users express skepticism, noting the treatment uses existing products.

RCH-01's progress is uncertain, and there's skepticism about its effectiveness. Users are losing hope in this treatment.

PP405 shows initial promise for treating androgenetic alopecia, with safety confirmed in early trials, but skepticism remains due to limited data. Further trials are needed to determine its true efficacy and potential market impact.